Bank of America
XAGE

Bank of America’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bank of America’s Portfolio XAGE Stock Details XAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6
Closed -$15 – 8799
2025
Q2 		$15 Hold
6
– – ﹤0.01% 8272
2025
Q1 		$24 Buy
6
+1
+20% +$10 ﹤0.01% 8104
2024
Q4 		$44 Sell
5
-16
-76% -$152 ﹤0.01% 7888
2024
Q3 		$250 Buy
21
+17
+425% +$464 ﹤0.01% 7521
2024
Q2 		$153 Buy
+4
New +$264 ﹤0.01% 7620
2024
Q1 		– Hold
0
– -$8 – 8270
2023
Q4 		– Hold
0
– – – 7817

Other funds holding XAGE

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
CMU
Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return

Bank of America's XAGE Position: Q3 2025 in Review

Bank of America sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2025, closing a stake of 6 shares — an estimated $15 sold.

Bank of America first reported a position in XAGE in Q2 2024 and held it in 5 quarters. The position peaked at $250 in Q3 2024. 3 funds tracked by Wall St. Rank hold XAGE as of Q3 2025.

  • Bank of America reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
  • Bank of America sold 6 Longevity Health Holdings, Inc. Common Stock shares in Q3 2025, an estimated $15.
  • Bank of America first reported a position in Longevity Health Holdings, Inc. Common Stock in Q2 2024 and held it in 5 quarters.
  • Bank of America's Longevity Health Holdings, Inc. Common Stock position peaked at $250 in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2025.

Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.